277 related articles for article (PubMed ID: 31221959)
1. Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation.
van Weverwijk A; Koundouros N; Iravani M; Ashenden M; Gao Q; Poulogiannis G; Jungwirth U; Isacke CM
Nat Commun; 2019 Jun; 10(1):2698. PubMed ID: 31221959
[TBL] [Abstract][Full Text] [Related]
2. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
[TBL] [Abstract][Full Text] [Related]
3. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
Huang C; Verhulst S; Shen Y; Bu Y; Cao Y; He Y; Wang Y; Huang D; Cai C; Rao K; Liao DF; Jin J; Cao D
Oncotarget; 2016 Jul; 7(28):43779-43791. PubMed ID: 27248472
[TBL] [Abstract][Full Text] [Related]
4. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
Liu W; Song J; Du X; Zhou Y; Li Y; Li R; Lyu L; He Y; Hao J; Ben J; Wang W; Shi H; Wang Q
Acta Biomater; 2019 Jun; 91():195-208. PubMed ID: 31034948
[TBL] [Abstract][Full Text] [Related]
5. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
[TBL] [Abstract][Full Text] [Related]
6. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.
Wang C; Yan R; Luo D; Watabe K; Liao DF; Cao D
J Biol Chem; 2009 Sep; 284(39):26742-8. PubMed ID: 19643728
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.
Quinn AM; Harvey RG; Penning TM
Chem Res Toxicol; 2008 Nov; 21(11):2207-15. PubMed ID: 18788756
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.
Luo D; Bu Y; Ma J; Rajput S; He Y; Cai G; Liao DF; Cao D
J Biol Chem; 2013 Dec; 288(51):36733-40. PubMed ID: 24217247
[TBL] [Abstract][Full Text] [Related]
9. AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells.
Huang C; Cao Z; Ma J; Shen Y; Bu Y; Khoshaba R; Shi G; Huang D; Liao DF; Ji H; Jin J; Cao D
Mol Carcinog; 2018 Oct; 57(10):1300-1310. PubMed ID: 29846015
[TBL] [Abstract][Full Text] [Related]
10. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis.
Duan W; Liu W; Xia S; Zhou Y; Tang M; Xu M; Lin M; Li X; Wang Q
J Transl Med; 2023 Aug; 21(1):547. PubMed ID: 37587486
[TBL] [Abstract][Full Text] [Related]
11. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
12. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
Matsunaga T; Morikawa Y; Haga M; Endo S; Soda M; Yamamura K; El-Kabbani O; Tajima K; Ikari A; Hara A
Toxicol Appl Pharmacol; 2014 Jul; 278(2):180-9. PubMed ID: 24813866
[TBL] [Abstract][Full Text] [Related]
13. Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer.
Yoshitake H; Takahashi M; Ishikawa H; Nojima M; Iwanari H; Watanabe A; Aburatani H; Yoshida K; Ishi K; Takamori K; Ogawa H; Hamakubo T; Kodama T; Araki Y
Int J Gynecol Cancer; 2007; 17(6):1300-6. PubMed ID: 17425679
[TBL] [Abstract][Full Text] [Related]
14. RNF152 Suppresses Fatty Acid Oxidation and Metastasis of Lung Adenocarcinoma by Inhibiting IRAK1-Mediated AKR1B10 Expression.
Zhu D; Nie Y; Zhao Y; Chen X; Yang Z; Yang Y
Am J Pathol; 2023 Oct; 193(10):1603-1617. PubMed ID: 37717980
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer.
Shinde A; Wilmanski T; Chen H; Teegarden D; Wendt MK
Breast Cancer Res; 2018 Jul; 20(1):76. PubMed ID: 30005601
[TBL] [Abstract][Full Text] [Related]
16. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
[TBL] [Abstract][Full Text] [Related]
18. Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.
Zhang SQ; Yung KK; Chung SK; Chung SS
Cancer Sci; 2018 Jun; 109(6):1970-1980. PubMed ID: 29617059
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aldo-keto reductase family 1 member B10 by unsaturated fatty acids.
Hara A; Endo S; Matsunaga T; Soda M; El-Kabbani O; Yashiro K
Arch Biochem Biophys; 2016 Nov; 609():69-76. PubMed ID: 27665999
[TBL] [Abstract][Full Text] [Related]
20. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
